The Clinical Implications of Cytochrome P450 Interactions With Opioids and Strategies for Pain Management
- 1 December 2012
- journal article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 44 (6) , S15-S22
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patientsEuropean Journal of Clinical Pharmacology, 2010
- Molecular Insights Into μ Opioid PharmacologyThe Clinical Journal of Pain, 2010
- Polymorphism of Human Cytochrome P450 2D6 and Its Clinical SignificanceClinical Pharmacokinetics, 2009
- Opioid MetabolismMayo Clinic Proceedings, 2009
- Genetic factors in pain and its treatmentCurrent Opinion in Anaesthesiology, 2007
- Metabolism of Antidepressant and Neuroleptic Drugs by Cytochrome P450s: Clinical and Interethnic AspectsClinical Pharmacology & Therapeutics, 2007
- High Carrier Prevalence of Deficient and Null Alleles of CYP2 Genes in a Major USA Hospital: Implications for Personalized Drug SafetyPersonalized Medicine, 2006
- Oxymorphone Extended Release Does Not Affect CYP2C9 or CYP3A4 Metabolic PathwaysThe Journal of Clinical Pharmacology, 2005
- Genetic Testing for Enzymes of Drug Metabolism: Does It Have Clinical Utility for Pain Medicine at the Present Time? A Structured ReviewPain Medicine, 2004
- Genetic Predictors of the Clinical Response to Opioid AnalgesicsClinical Pharmacokinetics, 2004